Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy: An Illustrative Example Focusing on the Primary Prevention of Coronary Heart Disease in Canada
Year of publication: |
1999
|
---|---|
Authors: | Morris, Stephen ; Godber, Ed |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 16.1999, 2, p. 193-205
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Pharmacoeconomics | Coronary-disorders | Antihyperlipidaemics | Cost-effectiveness | Hyperlipidaemia |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Hay, Joel W., (1999)
-
Cost Effectiveness of Coronary Heart Disease Prevention Strategies in Adults
Brown, Adalsteinn D., (1998)
-
Coukell, Allan J., (1998)
- More ...
-
Modelling the R&D Process for Global Diseases Driven By Public-Private Partnersips (PPPs)
Fenn, Paul, (2014)
-
Coordination, Spillovers, and Cheap Talk
Baliga, Sandeep, (2000)
-
Payoff Continuity in Incomplete Information Games
Kajii, Atsushi, (1997)
- More ...